Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 1, 2015, Pages 109-115

  Muhammad, Jibran Sualeh ^a   Zaidi, Syed Faisal ^a,b,c   Shaharyar, Saeeda ^b   Refaat, Alaa ^a   Usmanghani, Khan ^d   Saiki, Ikuo ^a   Sugiyama, Toshiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d HAMDARD UNIVERSITY   (Pakistan)

Author keywords

Cinnamaldehyde; Cinnamomum cassia; Helicobacter pylori; Human gastric epithelial cell; Interleukin 8; Nuclear factor kappa B

Indexed keywords

CINNAMALDEHYDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; ACROLEIN; ANTIINFLAMMATORY AGENT; IL8 PROTEIN, HUMAN;

AGS CELL LINE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DNA FRAGMENTATION ASSAY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MKN 45 CELL LINE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH EPITHELIUM; ANALOGS AND DERIVATIVES; CELL LINE; DRUG EFFECTS; HELICOBACTER INFECTIONS; METABOLISM; MICROBIOLOGY; TUMOR CELL LINE;

ACROLEIN; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL LINE, TUMOR; EPITHELIAL CELLS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; NF-KAPPA B;

EID: 84920532556     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00609     Document Type: Article

References (45)

1. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am. J. Med., 100(5A), 12S-17S, discussion, 17S-18S (1996).
2. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment. Pharmacol. Ther., 9(Suppl. 2), 33-39 (1995).
3. Muhammad JS, Sugiyama T, Zaidi SF. Gastric pathophysiological ins and outs of Helicobacter pylori. J. Pak. Med. Assoc., 63, 1528-1533 (2013).
4. Muhammad JS, Zaidi SF, Sugiyama T. Epidemiological ins and outs of Helicobacter pylori. J. Pak. Med. Assoc., 62, 955-959 (2012).
5. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum., 61, 1-241 (1994).
6. McColl KE. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med., 362, 1597-1604 (2010).
7. O'Connor A, Molina-Infante J, Gisbert JP, O'Morain C. Treatment of Helicobacter pylori Infection. Helicobacter, 18(Suppl. 1), 58-65 (2013).
8. Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW. Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J. Clin. Microbiol., 42, 4832-4834 (2004).
9. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch. Intern. Med., 161, 1217-1220 (2001).
10. Suzuki H, Inadomi JM, Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol. Motil., 21, 688-696 (2009).
11. Vítor JMB, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicines. FEMS Immunol. Med. Microbiol., 63, 153-164 (2011).
12. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J. Clin. Pathol., 48, 41-45 (1995).
13. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology, 113, 1099-1109 (1997).
14. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci., 96, 835-843 (2005).
15. Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit. Rev. Food Sci. Nutr., 50, 822-834 (2010).
16. Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J. Nutr. Biochem., 19, 347-361 (2008).
17. Usmanghani K, Hannan A, Gill MA. Herb Market Analysis for Karachi. MINFAL Research Project, Hamdard University, Pakistan, pp. 63 (2006).
18. Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement. Altern. Med., 13, 275 (2013).
19. Tabak M, Armon R, Neeman I. Cinnamon extracts' inhibitory effect on Helicobacter pylori. J. Ethnopharmacol., 67, 269-277 (1999).
20. Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilanj AH, Jafri W, Sugiyama T. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J. Ethnopharmacol., 141, 403-410 (2012).
21. Marchildon PA, Sugiyama T, Fukada Y, Peacock JS, Asaka M, Shimoyama T, Graham DY. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J. Clin. Microbiol., 41, 1480-1485 (2003).
22. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun., 68, 6265-6272 (2000).
23. Zaidi SF, Ahmed K, Yamamoto T, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Effect of resveratrol on Helicobacter pyloriinduced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol. Pharm. Bull., 32, 1931-1935 (2009).
24. Sellins KS, Cohen JJ. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol., 139, 3199-3206 (1987).
25. Hayashi S, Sugiyama T, Yachi A, Yokota K, Hirai Y, Oguma K, Fujii N. A rapid and simple method to quantify Helicobacter pylori adhesion to human gastric MKN-28 cells. J. Gastroenterol. Hepatol., 12, 373-375 (1997).
26. Hayashi S, Sugiyama T, Amano K, Isogai H, Isogai E, Aihara M, Kikuchi M, Asaka M, Yokota K, Oguma K, Fujii N, Hirai Y. Effect of Rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob. Agents Chemother., 42, 1895-1899 (1998).
27. Zaidi SF, Yamada K, Kadowaki M, Usmanghani K, Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J. Ethnopharmacol., 121, 286-291 (2009).
28. Crabtree JE. Gastric mucosal inflammatory responces to Helicobacter pylori. Aliment. Pharmacol. Ther., 10(Suppl. 1), 29-37 (1996).
29. Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NF-κB and AP-1 on Helicobacter pylori-induced IL-8 expression in AGS cells. Dig. Dis. Sci., 48, 257-265 (2003).
30. Zaidi SF, Yamamoto T, Refaat A, Ahmed K, Sakurai H, Saiki I, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter, 14, 588-595 (2009).
31. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917 (2010).
32. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108 (2005).
33. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer, 94, 153-156 (2001).
34. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer, 118, 3030-3044 (2006).
35. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, Fukatsu A, Ichiyama S, Ohta M. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am. J. Gastroenterol., 91, 1150-1156 (1996).
36. Ben-Baruch A, Michiel DF, Oppenheim JJ. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem., 270, 11703-11706 (1995).
37. Fuchs CS, Mayer RJ. Gastric carcinoma. N. Engl. J. Med., 333, 32-41 (1995).
38. López-Lázaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res., 52(Suppl. 1), S103-S127 (2008).
39. Hong JW, Yang GE, Kim YB, Eom SH, Lew JH, Kang H. Antiinflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement. Altern. Med., 12, 237 (2012).
40. O'Mahony R, Al-khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J. Gastroenterol., 11, 7499-7507 (2005).
41. Nir Y, Potasman I, Stermer E, Tabak M, Neeman I. Controlled trial of the effect of cinnamon extract on Helicobacter pylori. Helicobacter, 5, 94-97 (2000).
42. Kim DH, Kim CH, Kim MS, Kim JY, Jung KJ, Chung JH, An WG, Lee JW, Yu BP, Chung H. Y. Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde. Biogerontology, 8, 545-554 (2007).
43. Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M. H.pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinases, TRAF2 and TRAF6 in gastric cancer cells. Gastroenterology, 119, 97-108 (2000).
44. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell, 132, 344-362 (2008).
45. Wondrak GT, Villeneuve NF, Lamore SD, Bause AS, Jiang T, Zhang DD. The cinnamon-derived dietary factor cinnamic aldehyde activates the nrf2-dependent antioxidant response in human epithelial colon cells. Molecules, 15, 3338-3355 (2010).